Amneal receives abbreviated new drug application approval for eluryng, the first generic nuvaring

Amneal receives abbreviated new drug application approval for eluryng™, the first generic nuvaring®.amneal pharmaceuticals inc - has initiated commercialization activities for eluryng.amneal pharmaceuticals - announces fda approval of eluryng, one of 15 new products co expects to launch over next 18 to 24 months.
AMRX Ratings Summary
AMRX Quant Ranking